| Daniel Philip Lavery, MD | |
|
10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 | |
| (503) 652-2880 | |
| Not Available |
| Full Name | Daniel Philip Lavery |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 43 Years |
| Location | 10180 Se Sunnyside Rd, Clackamas, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023236783 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Westside | Hillsboro, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
The University of Illinois Chicago has been selected by the National Institutes of Health as the principal site of a multi-center collaborative in the Chicago area that will bolster research and outreach to help communities disproportionately affected by COVID-19.
Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.
Sports ministers from the organisation's 53 member states are meeting in Athens on the eve of the Olympics. They have issued an action plan to ensure that all Commonwealth countries can take part in the worldwide drive to rid drugs from sport.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
The University of Illinois Chicago has been selected by the National Institutes of Health as the principal site of a multi-center collaborative in the Chicago area that will bolster research and outreach to help communities disproportionately affected by COVID-19.
Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.
Sports ministers from the organisation's 53 member states are meeting in Athens on the eve of the Olympics. They have issued an action plan to ensure that all Commonwealth countries can take part in the worldwide drive to rid drugs from sport.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Philip Lavery, MD 3408 Chelan Dr, West Linn, OR 97068-9291 Ph: () - | Daniel Philip Lavery, MD 10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 Ph: (503) 652-2880 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
The University of Illinois Chicago has been selected by the National Institutes of Health as the principal site of a multi-center collaborative in the Chicago area that will bolster research and outreach to help communities disproportionately affected by COVID-19.
Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.
Sports ministers from the organisation's 53 member states are meeting in Athens on the eve of the Olympics. They have issued an action plan to ensure that all Commonwealth countries can take part in the worldwide drive to rid drugs from sport.
› Verified 9 days ago
Dr. Daniel Forrest Lotspeich, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Kaiser Permanente Department Of Internal Medicine, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Walter Peter Robertson Iv, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015 Phone: 503-652-2880 | |
Alice C Nayak, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9290 Se Sunnybrook Blvd, Suite 120, Clackamas, OR 97015 Phone: 503-215-2110 Fax: 503-215-2115 | |
Dr. Alexander Michael Kositch, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Cara Nicole Steinkeler, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Darya Blednova, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 10151 Se Sunnyside Rd Ste 100, Clackamas, OR 97015 Phone: 503-659-0880 Fax: 503-513-7425 |